Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Glaceum Logo
Glaceum Growth Score
69
CB Rank
130830
Heat Score
77
Glaceum is a company that develops drugs to treat metabolic diseases of aging by restoring mitochondrial function.
Founded
obfuscation
PrivateVenture - Series Unknown Seongnam, Kyonggi-do, South Korea11-50 www.glaceum.com
Biotechnology
Pharmaceutical
Product Research
Overview

Glaceum
Total Funding
obfuscation
Growth Score
69
Heat Score
77

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score69
-2 pts
in past quarter
Heat Score 77
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Glaceum

CB Rank
130830
Glaceum is a company that develops drugs to treat metabolic diseases of aging by restoring mitochondrial function.
Founded
obfuscation
PrivateVenture - Series Unknown Seongnam, Kyonggi-do, South Korea11-50 www.glaceum.com
Biotechnology
Pharmaceutical
Product Research

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation

Details

Legal Name GLACEUM INC.
Also Known As 글라세움
Operating Status Active
Company Type For Profit
Phone Number +82 31 8002 2040
Contact Email rapanooi@glaceum.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Vutiglabridin
A drug candidate that acts as a paraoxonase-2 agonist to promote autophagy activation and improve mitochondrial function, targeting metabolic diseases such as non-alcoholic steatohepatitis (NASH).
HSG4112
A drug candidate designed to treat age-related macular degeneration (AMD) and retinitis pigmentosa (RP) by targeting retinal pigment epithelium (RPE) cells and modulating anti-VEGF pathways.

Research & Development

Glaceum is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Glaceum Logo
Venture Round - Glaceum
1
obfuscation
NeurobionetVenture - Series Unknown
obfuscation
Venture Round - Glaceum Logo
Venture Round - Glaceum
1
obfuscation
NeurobionetVenture - Series Unknown
obfuscation
Venture Round - Glaceum Logo
Venture Round - Glaceum
1
obfuscation
NeurobionetVenture - Series Unknown
obfuscation
Venture Round - Glaceum Logo
Venture Round - Glaceum
1
obfuscation
NeurobionetVenture - Series Unknown
obfuscation
Venture Round - Glaceum Logo
Venture Round - Glaceum
1
obfuscation
NeurobionetVenture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Glaceum Logo
Venture Round - Glaceum
1
obfuscation
NeurobionetVenture - Series Unknown
obfuscation
Venture Round - Glaceum Logo
Venture Round - Glaceum
1
obfuscation
NeurobionetVenture - Series Unknown
obfuscation
Venture Round - Glaceum Logo
Venture Round - Glaceum
1
obfuscation
NeurobionetVenture - Series Unknown
obfuscation
Venture Round - Glaceum Logo
Venture Round - Glaceum
1
obfuscation
NeurobionetVenture - Series Unknown
obfuscation
Venture Round - Glaceum Logo
Venture Round - Glaceum
1
obfuscation
NeurobionetVenture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Neurobionet Logo
Neurobionet
Yes
Venture Round - Glaceum Logo
Venture Round - Glaceum
—
Neurobionet Logo
Neurobionet
Yes
Venture Round - Glaceum Logo
Venture Round - Glaceum
—
Neurobionet Logo
Neurobionet
Yes
Venture Round - Glaceum Logo
Venture Round - Glaceum
—
Neurobionet Logo
Neurobionet
Yes
Venture Round - Glaceum Logo
Venture Round - Glaceum
—
Neurobionet Logo
Neurobionet
Yes
Venture Round - Glaceum Logo
Venture Round - Glaceum
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News

News and Press

News•Dec 8, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

463
349.51%
 in past month

Active Website Tech Count

6Glaceum is actively using 6 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Content Delivery Network.

Total IP

20The intellectual property of Glaceum includes 18 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Glaceum has registered 2 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Glaceum's headquarters? Glaceum is located in Seongnam, Kyonggi-do, South Korea.Who invested in Glaceum? Glaceum is funded by Neurobionet.When was the last funding round for Glaceum? Glaceum closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Glaceum's competitors? Alternatives and possible competitors to Glaceum may include Madrigal Pharmaceuticals, Inventiva Pharma, and  Altimmune.How much funding has Glaceum raised to date? Glaceum has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|